CAMBRIDGE, Mass. (AP) _ Sage Therapeutics Inc. (SAGE) on Thursday reported a loss of $55.9 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.50.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.
For the year, the company reported that its loss widened to $159 million, or $4.75 per share.
Sage Therapeutics shares have risen 21 percent since the beginning of the year. The stock has climbed 87 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SAGE at https://www.zacks.com/ap/SAGE
Keywords: Sage Therapeutics, Earnings Report